Commissioning and Quality Assurance of RapidArc Radiotherapy Delivery System: In Regard to Ling et al. (Int J Radiat Oncol Biol Phys 2008;72;575–581): Absence of Data Does Not Constitute Proof; The Proof is in Tasting the Pudding

Mehta, Minesh P.; Hoban, Peter; Mackie, T

doi:10.1016/j.ijrobp.2009.01.083

Cited by 15 publications

(4 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, as pointed out by the authors, the tests they devise do not thoroughly test the complete system and leave room for improvement. 48,49 Further, Ling et al do not consider patient specific QA nor TPS QA. It is the aim of the present work to present a comprehensive commissioning and QA program for RA.…”

Section: Introductionmentioning

confidence: 99%

Implementing RapidArc into clinical routine: A comprehensive program from machine QA to TPS validation and patient QA

Esch¹,

Huyskens²,

Behrens

et al. 2011

Medical Physics

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Implementing RapidArc into clinical routine: A comprehensive program from machine QA to TPS validation and patient QA

Esch¹,

Huyskens²,

Behrens

et al. 2011

Medical Physics

View full text Add to dashboard Cite

show abstract

“…The capability of IMAT in creating highly conformal dose distributions, especially in the single-arc form, has been a subject of debate (Bortfeld and Webb 2009, Mehta et al 2009, Ling et al 2009, Mohan 2009. In principle, the more freedom we give to the planning system, the better quality of plans can be generated.…”

Section: Discussionmentioning

confidence: 99%

Intensity-modulated arc therapy: principles, technologies and clinical implementation

2011

View full text Add to dashboard Cite

Intensity-modulated arc therapy (IMAT) was proposed by Yu (1995 Phys. Med. Biol. 40 1435-49) as an alternative to tomotherapy. Over more than a decade, much progress has been made. The advantages and limitations of the IMAT technique have also been better understood. In recent years, single-arc forms of IMAT have emerged and become commercially adopted. The leading example is the volumetric-modulated arc therapy (VMAT), a single-arc form of IMAT that delivers apertures of varying weights with a single-arc rotation that uses dose-rate variation of the treatment machine. With commercial implementation of VMAT, wide clinical adoption has quickly taken root. However, there remains a lack of general understanding for the planning of such arc treatments, as well as what delivery limitations and compromises are made. Commercial promotion and competition add further confusion for the end users. It is therefore necessary to provide a summary of this technology and some guidelines on its clinical implementation. The purpose of this review is to provide a summary of the works from the radiotherapy community that led to wide clinical adoption, and point out the issues that still remain, providing some perspective on its further developments. Because there has been vast experience in IMRT using multiple intensity-modulated fields, comparisons between IMAT and IMRT are also made in the review within the areas of planning, delivery and quality assurance.

show abstract

“…There are reports trying to quantify the respective advantages of each system; see Beavis (2004) and Korreman et al (2010) and, for more lively debates, see Bichay et al (2008), Ling et al (2008), Bortfeld and Webb (2009), Ling et al (2009), Mehta et al (2009), Mohan (2009), Otto (2009. Be aware that it is sometimes difficult to separate commercial, scientific and clinical arguments.…”

Section: Introductionmentioning

confidence: 99%

The concept and challenges of TomoTherapy accelerators

Bailat¹,

Baechler²,

Moeckli³

et al. 2011

Rep. Prog. Phys.

View full text Add to dashboard Cite

A currently used intensity-modulated radiotherapy system is the TomoTherapy® Hi-Art® accelerator (Tomotherapy Inc., Madison, WI, USA), which started clinical treatments at the beginning of the new millennium. The innovative idea behind tomotherapy units is to marry an x-ray computed tomography unit with a linear particle accelerator. This concept has answered some of the needs of the medical physicist community, but epidemiological evaluations are still needed in order to compare the technique with other modalities. This paper summarizes the basic concepts of tomotherapy units as well as current challenges and implications for users.

show abstract

Commissioning and Quality Assurance of RapidArc Radiotherapy Delivery System: In Regard to Ling et al. (Int J Radiat Oncol Biol Phys 2008;72;575–581): Absence of Data Does Not Constitute Proof; The Proof is in Tasting the Pudding

Cited by 15 publications

References 13 publications

Implementing RapidArc into clinical routine: A comprehensive program from machine QA to TPS validation and patient QA

Implementing RapidArc into clinical routine: A comprehensive program from machine QA to TPS validation and patient QA

Intensity-modulated arc therapy: principles, technologies and clinical implementation

The concept and challenges of TomoTherapy accelerators

Contact Info

Product

Resources

About